Accenture plcACN
NYSE • Technology
$193.84
P/E
15.90
PEG
0.22
FCF Yield
—
Rev Growth YoY
+727.0% YoY
Gross Margin
3203.0%
Health Score
7/10
D/E Ratio
0.17
Confidence
LOW
Business Snapshot
Accenture plc is a global professional services and technology company, providing consulting, strategy, digital transformation, and managed services across virtually every major industry vertical. The firm operates in the highly competitive Information Technology Services space, competing for enterprise contracts worldwide. Based on available valuation ratios and its NYSE listing, Accenture is a large-cap company by any conventional measure.
Financial Health
Score: 7/10
Accenture carries a conservative balance sheet with a debt/equity ratio of just 0.17x, indicating the company is not meaningfully leveraged and has limited refinancing risk. The current ratio of 1.42x suggests adequate near-term liquidity, meaning current assets comfortably cover current liabilities...
Risk Assessment
- TECHNICAL TREND: Price at $193.84 is trading below both the 50-day MA ($214.89) and the 200-day MA ($247.81), with an active death cross formation, signalling an established downtrend.
- DRAWDOWN: ACN is trading approximately 40.5% below its 52-week high of $325.71, indicating sustained and material price deterioration over the past year.
- DATA INTEGRITY: Reported gross margin of 3,203% and net margin of 1,061% are almost certainly erroneous data artefacts, undermining the reliability of the margin and revenue growth figures in this payload.
- MISSING CORE DATA: Free cash flow, TTM revenue, TTM net income, and DCF fair value are all unavailable, preventing a complete fundamental assessment and reducing conviction in any directional rating.
- ANALYST TARGET ABSENT: No average analyst price target is available, making it impossible to quantify the consensus upside or downside from current levels.
---...
**Score: 7/10** Accenture carries a conservative balance sheet with a debt/equity ratio of just 0.17x, indicating the company is not meaningfully leveraged and has limited refinancing risk. The current ratio of 1.42x suggests adequate near-term liquidity, meaning current assets comfortably cover current liabilities. The gross margin figure reported in the payload is anomalous at 3,203% and the net margin at 1,061%, which are likely data artefacts rather than true operational metrics and should be treated with caution; free cash flow data is also absent, which limits a complete assessment of capital generation quality. The score reflects the strength of the debt profile while acknowledging that key profitability validation is unavailable. ---
- **TECHNICAL TREND:** Price at $193.84 is trading below both the 50-day MA ($214.89) and the 200-day MA ($247.81), with an active death cross formation, signalling an established downtrend. - **DRAWDOWN:** ACN is trading approximately 40.5% below its 52-week high of $325.71, indicating sustained and material price deterioration over the past year. - **DATA INTEGRITY:** Reported gross margin of 3,203% and net margin of 1,061% are almost certainly erroneous data artefacts, undermining the reliability of the margin and revenue growth figures in this payload. - **MISSING CORE DATA:** Free cash flow, TTM revenue, TTM net income, and DCF fair value are all unavailable, preventing a complete fundamental assessment and reducing conviction in any directional rating. - **ANALYST TARGET ABSENT:** No average analyst price target is available, making it impossible to quantify the consensus upside or downside from current levels. ---
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives